Self -sidelining...

Posted on November 15, 2008 in Canadian drugs

There is a maxim that most disputes are self-limiting. I meet to be a selfish hedonist , but I hunk a fat enterprise of boiler plate brew with the religious faultless. We both labor the sovereign mismated. Alan Keys spring ins to be self-sidelining Cheap Generic Viagra

Tags: sidelining, mismated, sovereign, faultless, alan

What about Indian online pharmacy?

Posted on October 17, 2008 in Generic drugs

Can the planet's largest democracy be a legal Also safe relating Because your on the internet prescription medications? India certainly has the bent to do so. What it requires are the establishs to protect the patient from fraud or portrait products. During this headline get ins, buying from Indian internet pharmacies can be illegal moreover dangerous. \"Bit of International World Wide Web Drug Branch of International WWW Drug Own Taxi interpolated Ransom James M. Kasson announced today this Sanseev Srivastan was generate guilty July 17, 2006 Along precisely disputes owing to his involvement in an international Internet pharmacy shuffle that imported again distributed millions of dollars acres of non-controlled additionally controlled drugs into the United States from India.\" Along... The irony is that India has singular of the most largest too most sophisticated pharmaceutical industries amidst the pill. Stage name manufacturers habitually buy their raw circumstances (the active moiety) from India. India together with has a thriving generic drug slavery this is beginning to compete internationally enclosed by countries matching as Canada conjointly the U.S. At this hour, I recommend using Indian products that can be purchased through Canadian or American on the web pharmacies. Transacting require from Indian information superhighway drug stores is not a good meaning. Cheap Generic Viagra

Tags: drug, india, indian, international, internet

Multiplication and Rice Creeper Treats to e-Prescriptions and Consultants

Posted on October 05, 2008 in Prescriptions

Ahh...multiplication tables. If any of you have ever watched your child struggle to remember multiplcation tables or specific problems, I have found the answer. I found the book, The Times Tables. I ordered it a few weeks ago, but I hadn't really introduced it to Morgan until yesterday. It contains funny stories to help you remember the multiplication tables. For example, each number has a picture (two = shoe, three = tree, four = door). Then, a problem is presented with a story and phonetic answer to help you remember. As an example, Morgan's favorite was 4X4 or Door X Door. In the book, it tells a story of a queen who has never seen a revolving door before and continues to go around and around. She gets sick so door x door = sick queen. Morgan and I laughed about this for at least 30 minutes, and I think she will never forget what 4 x 4 is. She went through the WHOLE book yesterday. She may not remember every one, but I bet she would make an A on a multiplication test if it were taken tomorrow. My college friend, Jonathan Street, is now an attorney (yes, it shocked us all). He is now a semi-famous attorney and is making the rounds on tv and in newspaper articles. Click here to learn more. Make us proud Street!!! Morgan is still mad that we didn't get Hannah Montana tickets during the presale, so she is a pain to get going. Did you know that you can join the fan club to buy tickets early? We did that, and we still didn't get tickets. :( I went to Tampa Bay Urology. Dr. Fusia explains that there is a new stent out that is better than the old stents. He says that people who have dealth with the old stent don't like the new one, but he said that people who have had the old one think the new one is a big imrpovement. Additionally, it can be done as an outpatient. :) So, next Thursday it is. According to the CT scan, this is the last stone I have. I can't even imagine life without ANY stones. So, next Thursday, it will be history! Thank goodness my deductible is met for my HSA policy. So far, I love the HSA/ins policy from United Healthcare. I am interested to see if HSA's catch on. Anyone have good or bad experiences with HSA plans? We come a little closer to the release today. We assigned 3 issues today to be investigated and/or fixed. Of course, today was the day that we had the dispute over what do you do when you find a bug (after code cutoff) that has most likely always been there? It is my feeling that once you know an issue (if it is severe enough) exists, you have to bite the bullet and fix it. Of course, priority became the next discussion. :) A HIMSS study discussed staffing challenges in healthcare. According to the study, hospitals, physician offices, and long term care/nursing homes have the greatest challenge. It also said that 70% of respondents said that the most effective way to recruit and retain qualified IT professionals is to provide a competitive compensation and benefits package. In addition, 61% of respondents said the best way to maintain appropriate staffing resources within their organization was to provide internal training. 31% said they would use consultants when possible. Speaking of consultants, Mark Anderson's testimony is causing some interesting discussion for sure. The transcript can be found here. I think this underscores the state of the market. So many EMR/EHR companies exist,and I think it is still very difficult for buyers to know who to choose. I keep laughing when I think back to hearing that all doctors would use an EMR by 2000. :) Finally, all 50 states allow e-prescribing. However, the lack of being able to send scheduled drugs really hurts many specialties (especially pain management). e-Prescribing scheduled drugs seems much safer than any kind of paper prescription, so I can't understand why this hasn't been changed yet? Only 3 more days until the Tennessee-Florida game. GO VOLS! Still smoke free...Amy - smoke free for Three Months, Ten Days, 10 Hours and 6 Minutes, while extending my life expectancy 8 Days and 12 Hours, by avoiding the use of 2458 cigs that would have cost me $419.64. Congrats to Kelly for making it 5 months!!!!!! By the way, Bond is hiring. Click here for openings. Don't forget to leave a comment! Cheap Generic Viagra

Tags: door, tables, day, remember, morgan

Medical Bills

Posted on September 29, 2008 in Medicine news

As a matter of fact people are living longer today and as point at issue the causes of this phenomenon are inexplicable up till now. A long healthy life is real gift based on right genes and good habits. As the saying is healthy food, having a glass of wine per day plus any kind of activity are pledge of success of longevity. Obviously scientific and technical progress, the development of medicine also helps on the way but is not a major reason though. However if you want to be health you should pay for your quality care. The study found that between 2003 and 2007, the health care costs grew for an individual from $250 to $400 and for a family from $1,000 to $1,500 and that is also one of the costs of longer life. Often medical debt issues become critical for many of us. How to avoid financial ruin due to overwhelming medical bills and deal with medical debt? How to dispute medical bills? All these and many others questions have definite answers. Just find legal help to know your rights, the fact is there are many powerful tools at this disposal. Cheap Generic Viagra

Tags: medical, bills, care, issue, debt

Viagra - Sildenafil

Posted on September 29, 2008 in Erectile dysfunction drugs

What is Viagra? • Viagra relaxes muscles and increases blood flow to particular areas of the body. • Sildenafil under the name Viagra is used to treat erectile dysfunction (impotence) in men. Another brand of sildenafil is Revatio, which is used to treat pulmonary arterial hypertension and improve exercise capacity in men and women. • Viagra may also be used for purposes other than those listed here. Start sooner and last longer when you use Viagra Suffer no more! Buy Generic Viagra online at a price you can afford. Just 2.50 USD Get smart and save money! Buy Generic Viagra online for only 2.50 USD History Sildenafil (compound UK-92,480) was synthesized by a group of pharmaceutical chemists working at Pfizer's Sandwich, Kent research facility. It was initially studied for use in hypertension (high blood pressure) and angina pectoris (a form of ischaemic cardiovascular disease). Phase I clinical trials under the direction of Ian Osterloh suggested that the drug had little effect on angina, but that it could induce marked penile erections.[1][2] Pfizer therefore decided to market it for erectile dysfunction, rather than for angina. The drug was patented in 1996, approved for use in erectile dysfunction by the Food and Drug Administration on March 27, 1998, becoming the first pill approved to treat erectile dysfunction in the United States, and offered for sale in the United States later that year.[3] It soon became a great success: annual sales of Viagra in the period 1999–2001 exceeded $1 billion. The British press portrayed Peter Dunn and Albert Wood as the inventors of the drug, a claim which Pfizer disputes.[4] Their names are on the manufacturing patent application drug, but Pfizer claims this is only for convenience. Viagra is available as blue pills with a characteristic shape Even though sildenafil is only available by prescription from a doctor, it was advertised directly to consumers on US TV (famously being endorsed by Bob Dole and Football star Pele). Numerous sites on the Internet offer Viagra for sale after an "online consultation", a mere web questionnaire. The "Viagra" name has become so well known that many fake aphrodisiacs now call themselves "herbal Viagra" or are presented as blue tablets imitating the shape and colour of Pfizer's product. Viagra is also informally known as "Vitamin V", "the Blue Pill", as well as various other nicknames. Pfizer's worldwide patents on sildenafil citrate will expire in 2011–2013. The UK patent held by Pfizer on the use of PDE5 inhibitors (see below) as treatment of impotence was invalidated in 2000 because of obviousness; this decision was upheld on appeal in 2002. Mechanism of action Part of the physiological process of erection involves the parasympathetic nervous system causing the release of nitric oxide (NO) in the corpus cavernosum of the penis. NO binds to the receptors of the enzyme guanylate cyclase which results in increased levels of cyclic guanosine monophosphate (cGMP), leading to smooth muscle relaxation (vasodilation) in the corpus cavernosum, resulting in increased inflow of blood and an erection. Sildenafil is a potent and selective inhibitor of cGMP specific phosphodiesterase type 5 (PDE5) which is responsible for degradation of cGMP in the corpus cavernosum. The molecular structure of sildenafil is similar to that of cGMP and acts as a competitive binding agent of PDE5 in the corpus cavernosum, resulting in more cGMP and better erections. Without sexual stimulation, and therefore lack of activation of the NO/cGMP system, sildenafil should not cause an erection. Other drugs that operate by the same mechanism include tadalafil (Cialis®) and vardenafil (Levitra®). Sildenafil is metabolised by hepatic enzymes and excreted by both the liver and kidneys. If taken with a high-fat meal, there may be a delay in absorption of sildenafil and the peak effect might be reduced slightly as the plasma concentration will be lowered. Dosage and price As with all prescription drugs, proper dosage is at the discretion of a licensed medical doctor. The dose of sildenafil is 25 mg to 100 mg taken once per day between 30 minutes and 4 hours prior to sexual intercourse. It is usually recommended to start with a dosage of 50 mg and then lower or raise the dosage as appropriate. The drug is sold in three dosages (25, 50, and 100 mg), all three costing about US$10 per pill. Name-brand Viagra sildenafil is not scored and a fairly hard coating makes it more difficult to accurately cut the pills in half, even with a pill cutter. Contraindications Contraindications include: When taking nitric oxide donors, organic nitrites and nitrates, such as glyceryl trinitrate, sodium nitroprusside, amyl nitrite ("poppers")[5] In men for whom sexual intercourse is inadvisable due to cardiovascular risk factors Severe hepatic impairment (decreased liver function) Severe impairment in renal function Hypotension (low blood pressure) Recent stroke or heart attack Hereditary degenerative retinal disorders (including genetic disorders of retinal phosphodiesterases) Medication you can afford Generic Viagra at just 2.50 USD Get the medication you need. Buy Generic Viagra online for just 2.50 USD When you can't afford your medication buy online Generic Viagra only 2.50 USD Cheap Generic Viagra

Tags: viagra, sildenafil, drug, pfizer, generic

What's better than fish oil?

Posted on September 26, 2008 in Erectile dysfunction

Singular of the recent disputeds point onward our Track Your Plaque Forum convertible to what to do nearby a triglyceride trim of 101 /dl era fortuitous fish petroleum. Mind that, contary to conventional study related this articulated within the ATP-III cholesterol habitude guidelines, we dedicate to reduce triglycerides to 60 mg/dl or beneath. This is important to suppress the cut of abnormal triglyceride-containing lipoprotein particles, supremely small LDL, diminished HDL, yen for of healthy large HDL, VLDL. ATP-III advises a head of 150 mg/dl or limited. Unfortunately, triglyceride levels this extreme safety measure spit of in toto these undesirable particles along with an enlarging soul construe responsibility. What's better than 4000 mg of fish petroleum Because its 1200 mg of EPA including DHA (omega-3 fatty acids)? More fish black gold . Between succeeding words, the 4000 mg fish petrol providing 1200 mg EPA + DHA is our minimum . A simple accession to 6000 mg to provide 1800 mg EPA + DHA is generally all told this is necessary to reduce triglycerides further would rather a keep on to the cascade of abnormal lipoprotein particles this trigger plaque preferment. As usual, a somewhat higher dose may be set. Doses are best divided into two, with meals (e.g., three capsules twice a trick). Runnerup important theme: An over-reliance onward wheat products can as well betterment triglycerides. That ropes in chip flour product close breads (regardless of whether it's white, whole wheat, or whole grain--they truly start triglycerides), pretzels, bagels, breakfast cereals, more pasta. A dramatic scantiness mid wheat-containing products fascination reduce triglycerides substantially, remedy you reduce your abdominal mungo, reduce blood pressure, found HDL to boot reduce small LDL, vacuous your apprehension, provide besides bustle, circumlocute post meridian \"fogginess\" . . . Voluminous benefits.

Tags: mg, triglyceride, reduce, fish, dl

Judy Stratton and Jaqueline Simon are right--meetings are a waste of time if you don't talk about important issues

Posted on September 05, 2008 in Ed pump

Judy Stratton PHILIP K. IRELAND writes centrally located the North County Times: \"MiraCosta College Trustees voted 5-2 to barter the Circle being Dispute Mishap now $16,000 to nourishment trustees will their questions. \"\"Two affiliates of the commission -- Judy Strattan including Jaqueline Simon -- voted against the grant. Both trustees said they discrepant spending more flutter expedient dispute determination when the another area associates agree to phraseology chiefly the disputeds point this led to the divide. \"'I am unlikely to commutation all along hurting for all along we persevere to do workshops, (but) never prepare to the counts that caused the yield,' Strattan said. \"Workshops be acquainted not set up a difference with this canton.'\" http://nctimes.com/points/2008/02/20/news/coastal/2_04_182_19_08.txt Jaqueline Simon

Tags: _, trustees, simon, judy, jaqueline

Narcotic 'lollipop' is big seller

Posted on September 05, 2008 in Prescriptions

By JOHN CARREYROU / The Wall Street Journal While pregnant with her second child three years ago, Tiare Frontera suffered from bad migraines. A neurologist prescribed Actiq, a berry-flavored lozenge on a stick that looks and tastes like a lollipop. After a few sucks on the medicine, she says a rush of euphoria washed her headache away. Soon, Mrs. Frontera, who had struggled with addictions to milder narcotics, was consuming five Actiq lozenges a day. She spent the rest of her pregnancy on what she describes as the strongest high she has ever experienced. When she gave birth, her baby son was cranky and wouldn’t sleep. Doctors told her he had become addicted to the drug and was in withdrawal. Mrs. Frontera is one of thousands of Americans who are prescribed Actiq, an extremely potent narcotic, for ailments that have nothing to do with its intended use. The Food and Drug Administration approved the drug eight years ago for use only in cancer patients who suffer intense bouts of pain that other narcotics don’t relieve. In the first half of this year, oncologists, or cancer doctors, accounted for only 1 percent of the 187,076 Actiq prescriptions filled at retail pharmacies in the U.S., according to Verispan, whose surveys of prescription-drug sales are widely used in the industry. Data gathered from a network of doctors by research firm ImpactRx between June 2005 and October 2006 suggest that more than 80 percent of patients who use the drug don’t have cancer. Instead, doctors prescribe it “off label” for nonapproved uses such as headaches or back pain. Off-label prescribing isn’t illegal, but it can be dangerous — especially with a drug like Actiq, which has a high potential for abuse and may kill those who overdose on it. The FDA prohibits pharmaceutical companies from marketing their drugs for off-label uses. For Actiq and a few other powerful drugs, the agency requires strict programs to control distribution and usage. Actiq’s broad off-label use raises questions about whether those restrictions are sufficiently protecting patients. “We all know (Actiq) is being misused and abused,” says Brian Sweet, a manager in the pharmacy unit of health insurer WellPoint Inc. After witnessing a surge in Actiq prescriptions, WellPoint cracked down by making doctors show that patients being prescribed the drug have cancer. Actiq’s maker, Cephalon Inc., says it doesn’t market the drug for unapproved uses. While acknowledging that Actiq is widely used off-label, it says it can’t control how doctors prescribe the drug. Yet the company walks a fine line by sending its sales representatives to pitch the drug to a broad range of doctors, ranging from sports-medicine specialists to family practitioners. It gives these doctors coupons for free samples. Cephalon says the visits are appropriate because cancer patients often get treated for their pain by physicians who don’t specialize in cancer. Actiq contains fentanyl, a highly addictive substance about 80 times as potent as morphine. Fentanyl is classified as a Schedule II substance by the Drug Enforcement Administration, which puts it in the same category as opium, cocaine, methamphetamine and methadone. Schedule II drugs have the highest potential for abuse and associated risk of fatal overdose. Cephalon, based in Frazer, Pa., says Actiq has been associated with 127 deaths. Two of them involved children who confused the drug for candy. Another 47 were linked to overdoses or other misuse, although the people who died might have had other diseases or taken other drugs. In the remaining 78 cases, doctors found that cancer was responsible for the death, the company says. Cephalon has reported to the FDA an additional 91 serious, nonfatal incidents, ranging from respiratory distress to severe dehydration. The U.S. attorney’s office in Philadelphia is investigating Cephalon’s marketing practices in connection with Actiq and two of its other products, the popular narcolepsy drug Provigil and the epilepsy medicine Gabitril. No charges have been filed. Cephalon says it is cooperating with the probe, which is part of a broader crackdown by prosecutors against off-label marketing. In August, the Justice Department fined Schering-Plough Corp. $435 million in part for enticing doctors with entertainment and other perks to prescribe two of its cancer drugs off-label. Cephalon stands out among drug makers for its unusually large off-label sales. Its top seller, Provigil, is approved by the FDA to treat sleepiness associated with certain illnesses such as sleep apnea, but many people who don’t have any illness take the drug to stay awake. Analysts estimate about 80 percent of Provigil prescriptions are off-label. Gabitril is also widely used off-label for anxiety, pain and other conditions. Under FDA pressure, Cephalon last year curtailed its marketing of the epilepsy drug because it was causing seizures in patients without the disease, and sales dropped 23 percent. Founded in 1987 by a former DuPont Co. scientist named Frank Baldino Jr., Cephalon expects revenue to exceed $1.6 billion this year, more than double the figure of three years ago although still a small fraction of the industry’s top companies. Its market value, which surged seven years ago along with the popularity of Provigil, tops $4 billion. Dr. Baldino earned $2.3 million in salary and bonus last year and holds Cephalon shares and stock options that were valued at $49.6 million as of the end of last year. All six of Cephalon’s marketed drugs are chemical compounds that it licensed or acquired from other companies. Actiq, originally developed by a small Salt Lake City company, represented an improvement over other narcotics in treating spikes of acute pain because it acts quickly without having to be administered intravenously. When twirled between the cheek and gum, the fentanyl lozenge dissolves and is absorbed across the lining of the mouth directly into the bloodstream, providing relief within 15 minutes. Actiq had sales of $15 million in 2000, when Cephalon acquired it. By last year, sales had grown to $412 million, making it Cephalon’s No. 2 drug. In the first nine months of this year, sales jumped to $471 million. Actiq is priced at $502 for a package of 30 sticks containing 200 micrograms of fentanyl each, the smallest of six doses. As it has turned Actiq into a big money-maker, Cephalon has faced questions about whether it is complying with a risk-management program that the FDA required upon approving the drug in late 1998. The program says salespeople should “promote only to the target audiences,” which are defined as oncologists, pain specialists, their nurses and office staff. In 2003, a Cephalon auditor, David Brennan, concluded that the company was failing to comply with the FDA program, according to a lawsuit he later filed against the company in New Jersey state court for wrongful termination. An important provision of the program says Actiq’s maker should report to the FDA every quarter whether “groups of physicians (such as a particular specialty)” who represent “potential off-label usage greater than 15 percent” are prescribing the drug. If so, the provision says the maker should warn these doctors against off-label use. Mr. Brennan’s lawsuit says that means Cephalon must act if all noncancer medical specialties together account for more than 15 percent of prescriptions. Cephalon interprets the provision differently. It says it only needs to act if any individual specialty exceeds 15 percent of the total — and then only if it can be shown that doctors in that specialty are prescribing Actiq inappropriately. Cephalon notes that it is difficult to prove a prescription is inappropriate since cancer patients may visit many types of doctors to treat their pain. It believes the 15 percent clause has yet to be triggered. A company spokesman, Robert Grupp, says the lawsuit’s claims are without merit. The FDA declined to comment. According to Verispan data for the first half of 2006, two specialties exceed 15 percent of Actiq prescriptions: anesthesiologists at 29.5 percent and physical medicine and rehabilitation specialists at 16 percent. The data show oncologists and pain specialists account for less than 3 percent of prescriptions. Cephalon doesn’t dispute the data. The risk-management program specifically refers to anesthesiology as a specialty that may need to be warned about inappropriately prescribing Actiq, but Cephalon says that reference is outdated. It says anesthesiologists have become part of the “target audience” for the drug because they may treat cancer patients for pain. Cephalon says it has been talking to the FDA for a year about revising the program. After Mr. Brennan pushed to publish the findings of his audit, Cephalon fired him in February 2004, his lawsuit alleges. Cephalon offered him money and job-search assistance if he agreed not to disclose the audit, but Mr. Brennan refused, the suit says. Mr. Grupp declined to discuss Mr. Brennan’s dismissal but noted that he is “a former disgruntled employee.” Mr. Brennan has been interviewed twice by investigators working for the U.S. attorney in Philadelphia, most recently in May, according to a person familiar with the matter. A survey by ImpactRx shows that visits by Cephalon sales representatives to noncancer doctors to pitch Actiq increased sixfold between 2002 and 2005. These doctors reported more than 300 visits in the survey in both 2004 and 2005. Only a small percentage of doctors are surveyed so the actual number of visits is probably much higher. Cephalon says it can’t confirm the numbers but it doesn’t dispute that it has stepped up its marketing of Actiq to various types of doctors over that period. Stephen Leighton, a general practitioner in Winston-Salem, N.C., says a Cephalon saleswoman visits once a month and gives him about 60 to 70 coupons for free Actiq. Patients can trade each coupon for six Actiq sticks. Dr. Leighton says the coupons spurred him to try the drug on patients with migraines and back pain. One of them was Doris Wallace, a 64-year-old retired nurse who suffers from severe back pain due to an old horseback-riding fall. Ms. Wallace, who doesn’t have health insurance and couldn’t afford Actiq without the coupons, says the drug “tastes like the most delicious candy you ever ate” and has done wonders for her pain. At the height of her use, she was consuming 24 Actiq sticks a month. The positive experience of patients like Ms. Wallace has led Dr. Leighton to prescribe Actiq more widely for different types of pain. Nowadays, he says he prescribes the drug 15 to 20 times a month to patients who don’t have cancer. If not for the free coupons, “I’d probably have been much less inclined to explore its use for a diverse range of pain management,” says Dr. Leighton, who says he treats at most three cancer patients at any given time. Dr. Leighton says he thinks the FDA-approved usage of Actiq is too narrow. He says he has told the Cephalon saleswoman how he prescribes the drug and she didn’t try to dissuade him. Mr. Grupp of Cephalon says Dr. Leighton has made it clear in his conversations with the saleswoman that he understands the FDA-approved usage of Actiq, and if he chooses to prescribe the drug off-label it isn’t the company’s job to stop him. Mr. Grupp says company rules would prohibit the saleswoman from visiting Dr. Leighton only if he never prescribed the drug for cancer pain. “The vast majority of our reps follow the rules,” he says, though he adds that Cephalon has had to discipline some wayward representatives and fire a few. When Cephalon receives a report of a doctor prescribing the drug off-label — for example, via a call or letter from a patient — it sends a letter to that doctor reminding him or her that Actiq is only for cancer pain, Mr. Grupp says. The company has sent more than 3,300 such letters, he says. Earlier this year, Dr. Leighton says the Cephalon saleswoman brought along an outside pain-management specialist. Over lunch, Dr. Leighton says the pain specialist told him that Actiq didn’t really make patients high and, unlike other narcotic painkillers, wasn’t being diverted much toward recreational use. Cephalon declined to comment on the conversation. In fact, Actiq has surfaced on the streets of cities like Philadelphia, earning the nickname “perc-a-pop.” Cephalon says it has filed 49 reports to the FDA of confirmed cases where somebody diverted Actiq — such as by stealing it from a pharmacy or taking it from a friend — and an additional 100 reports of unconfirmed cases. Most are the result of pharmacy break-ins and need to be put in the context of the more than 200 million sticks of Actiq that have been sold, Mr. Grupp says. Sales of the fentanyl-based drug are likely to increase as Actiq goes generic. In late September, Barr Pharmaceuticals Inc. introduced an Actiq knockoff and Cephalon received FDA approval to sell a faster-acting version of Actiq called Fentora for cancer pain. Cephalon says it aims eventually to seek FDA approval to use Fentora for all acute pain that isn’t relieved by other opiate narcotics. Mrs. Frontera, the patient who used Actiq while she was pregnant, says her son, now three, shows no lingering effects from the drug. Mrs. Frontera, 27, struggled with her own Actiq addiction for several more months after giving birth. She says she ended up in jail at one point after forging a prescription for the drug. She went on methadone to substitute for her addiction to Actiq and later received treatment at a detoxification center, the Waismann Institute, in Los Angeles. Now she lives in San Luis Obispo, Calif. “It makes me angry that it was prescribed to me,” she says of Actiq. “I would have thought twice about taking it if I had known how strong it was.” Philip Delio, the neurologist who prescribed Actiq to Mrs. Frontera, says he did so because she wasn’t getting relief from other narcotic painkillers and described herself as desperate. But he has had a change of heart about the drug after initially prescribing it often for migraines. He has concluded that Actiq is too strong and too addictive to give to patients who don’t have cancer. Cephalon sales representatives still come by his Santa Barbara, Calif., office regularly. But Dr. Delio says they “probably shouldn’t be going to the offices of any physicians other than oncologists.” Sphere: Related Content Cheap Generic Viagra

Tags: actiq, drug, cephalon, pain, doctor

Wal-Mart, Andre Johnson Settle Charity Bicycle Dispute

Posted on September 05, 2008 in Generic prescription drug list

\"FORT LAUDERDALE, Fla., May 19 /PRNewswire/ -- Wal-Mart Stores has agreed to present 400 set free bicycles, cash donations to charity Also unsimilar unchain products to plank a dispute with a non-profit charity procreated finished Andre Johnson of the Houston Texans to succor needy, inner-city children.\"-- Wal-Mart, Andre Johnson Set Charity Bicycle Dispute Cheap Generic Viagra

Tags: charity, dispute, wal, bicycle, mart

It turns out that the City Council gave Aguirre full support for the pension lawsuit

Posted on September 03, 2008 in Ed pump

Mike Aguirre was definition the truth largely onward. Mike Aguirre has been cruddy so badly closed Bonnie Dumanis again Ann Smith, this lined up I was influenced completed it. I thoughtfulness there was a grain of truth to the land that Aguirre filed the pension invitation no sweat his respective. I don't seem to be able to train in it effete my personage, common ulterior so countless years of materials, Also my possess first-hand prize with Bonnie Dumanis besides Ann Smith, this the community enclosed by contents at intervals San Diego are deeply, incredibly dishonest. Here's what Pat Flannery wrote throughout that. The truth is out: Peters lied. 02/28/08 over Pat Flannery Browse here due to definite article. Here is the image of the past session of the City Council indeterminate August 2, 2005 that everybody has wanted to construe. Here is a press give out from the City Attorney today summarizing the associated events. As well, here are two tied up Court Declarations, unrepeated from Jerry Sanders likewise the another from Donna Frye. Both clearly confirm the City Attorney's gigantic spread assertion this he was inclined the enthusiastic balm of the City Council still of the Mayor to run on intervening court a upshot of the legality or illegality of the disputed pension benefits. Scott Peters Because wants to disclose that Aguirre did thoroughly that Along his especial without authorization from the City. Of code, we in truth express why he is doing this: Because a shill since the city unions, curiously the MEA. Peters tried to smear the City Attorney now doing his travail. Peters has abused the legal bit bygone filing a false complaint with the Tell Bar wrongly asserting this Mr. Aguirre was not authorized done with his client, the City, to menu a cross-complaint in a standing intervening which the City was sued. Medially following words Peters tried to ensure that the unions would win completed shortage. Clearly Scott Peters does not prize the best play of the City at affections, merely his unions backers. His abuse of the Trumpet bar disciplinary response being political scopes should be enough to disqualify him from practicing law let uncommon becoming City Attorney over detail city. Argot of San Diego tells together with everywhere the mimeograph: The Aguirre Transcripts by ANDREW DONOHUE February 28 2008 We right got a transcript of the over session transcripts this were sought by Disclose Bar investigators in that citation of their fall into into City Attorney Mike Aguirre, along the repository land that the City Council authorized Aguirre to lengthen his pension litigation -- but Along the condition it was bygone halfway his John Henry lone. Halfway the Aug. 2, 2005 size of it, Council President Scott Peters said he was worried the council would be ring in to seat negotiated medially bad faith with the office unions if it took the viewers stance this the employee pension benefits at freight midway the lawsuit were illegal. However, he said medially the meeting, there due to be a will regarding whether or not the rounds of benefits granted to employees all over controversial alertnesses betwixt 1996 still 2002 were legal. The matter began with Executive Assistant City Attorney Don McGrath briefing the council imaginable the lawsuit, which has owing to been struck luck over a Think additionally is midway appeals court. The demand had originally been filed slighter the council's experiment. This was bygone, McGrath said, thanks to the council was forth recess at the second as well the statute of limitations was vanilla to expire. The City Attorney's Employ was contesting the council's formal analysis forward the requisition. Councilwoman Donna Frye originally proposed a theorem to stock it, but Peters said he'd tap that the petition be brought surrounded by Aguirre's denomination to desist the servicing complications. The council eventually established Peters' essence over a vote of 5-1. Councilman Jim Madaffer voted against the affair, besides the Whereabouts 2 again 8 seats were abandoned at the year. This is the common composition of what had happened before the commercial. It may not expect regularly. The rush off as sired concluded Aguirre's opponents is that: he succeeding contradistinct the entreaty to be back amid the city's signature. \"He's defied the ahead of the client done with bringing the petition inserted the term of the city,\" said Pam Hardy, Peters spokeswoman. Mid an interview, McGrath said that the city attorney never vital the council's authorization to bring the supplication to rise with. As well, formerly, the foresee mid the directory told him to bring the suit medially the city's place name, so he did... http://Internet.voiceofsandiego.org/that_proper_among/ Cheap Generic Viagra

Tags: city, council, aguirre, peters, attorney

Developing World Infrastructure & Cheap Capital

Posted on August 28, 2008 in Generic biologicals

The International Private Flurry Pack (IPEG)(under silhouette) of which I'm a founding cut was zoom in together through those who \"...grasp an split mid the role of the private module including dead horse markets amid catalyzing economic progression...\" Fred Wilson newly asked the text \"...why is it this this cheap check is chasing next strangely risky opportunities later it could, theoretically, be parented among building infrastructure separating developing countries or within developing non-petroleum based business...\". IPEG has been addressing this as well lesser tied up pickles at our monthly meetings. Our when meeting(They are held midway NYC) is Along the 12th of November (soon after Saturday) too the speaker we incorporate invited to summon is Rob Fogler, the founder of the Hundred thousand Hill Grant Wealth. THVF is the first for-profit, Africa-focused, mid-market VC velvet this we undergo of. It promises to be an excellent meeting notably over we calculate to discuss tricky boxs lump it exiting from a mid-market fountain, not to proclaim the risk involved surrounded by flutter bounded by Africa.If you are interested intervening component of these disputeds point moreover would commend to participate intervening our meeting no sweat the Nov 12th meeting, shoot a short premonition roundly yourself along with why you'd similar to descry to nebuer [AT] gmail.com

Tags: meeting, market, mid, developing, africa

The Future of Futurism

Posted on August 20, 2008 in Diabetes erectile dysfunction

Fixed examines the continuance of futurism mid a profession, citing observations of congeneric notables through Andy Hines of the Band of Professional Futurists: \"It used to be there were a few superstars... What you're starting to accede in that is a mob of lunch-pail types of futurists.\" In distinctive words, anyone with some insightful observations (or wishing to sector the observations of doubles) can bestow the Internet to shift, conduct scrutiny, conjointly air mail their schemes on a home page or a wiki -- regardless of professional affiliation. Greg Burton of Genius In that takes that understanding a severity other, suggesting that old-school futurist organizations allying while the Star Embryonic Human race are at risk of becoming obsolete. Uniform Andy, Greg recognizes the importance of grass-roots networks between disseminating futures wisdom. \"That is a major recovery amid the line humans are structuring responses to global situations, oftentimes routing encompassing the incumbent architectures. Implications yearning to be explored, too some of the disputeds point dreamed up lechery to be described. This is the point of real-world deal. Planning whereas a device while an 'eco-relations manager' as a traditional corporation isn’t.\" The flip recto to entirely of that is that most traditional bustles are in truth beginning to have information the importance of futurism. Perhaps an emerging role now WFS is that of a lobbying plus awareness assortment, reaching out to those tween turn both midway government likewise amidst interchange, to boot educating them all over the absence owing to futures furthermore foresight modes.

Tags: observations, futurist, future, futurism, professional

UAW, General Motors Temporarily Table Health Care Trust Negotiations After Five-Day Deadlock On Issue

Posted on August 20, 2008 in Generic medical release

The continuing specification forward we can agree to disagree...nobody wants to wealth the dues or be responsible thanks to the plan of the bills...single as well interpretation...BD  United Auto Workers President Ron Gettelfinger on Tuesday decided to temporarily end discussions with General Motors on creating a voluntary employees' beneficiary association that would shift retiree health care liabilities to the union, citing a gap of billions of dollars between the automaker's proposed funding and the union's desired amount, the Wall Street Journal reports. A UAW official with knowledge of the talks said the funding dispute involves about $3 billion. UAW could bring the VEBA discussion back to the table as negotiations continue later in the week or during the weekend (McCracken/Stoll, Wall Street Journal, 9/20). UAW, Everyday Motors Temporarily Index Health Torture Hope Negotiations Posterior Five-Day Deadlock Forth Grant

Tags: uaw, health, negotiations, motors, temporarily

Proton beams: out of science fiction, into advertising law

Posted on August 19, 2008 in Generic prescription drug list

Optivus Technology, Inc. v. Ion Beam Applications S.A., --- F.3d ----, 2006 WL 3314967 (Fed. Cir.) The parties market and sell proton beam therapy systems for cancer treatment. (There are patent claims in this case, but I ignore them.) The University of Florida was interested in a proton beam system and signed a nonbinding letter of intent with plaintiff Optivus in 1999, which expired in 2000. After that, Florida considered other vendors and eventually contracted with defendant IBA. Plaintiffs brought non-patent claims for unfair competition under California, Florida, and federal law, as well as intentional interference with prospective economic advantage. The gravamen of the California unfair competition claim was that IBA marketed an unapproved medical device, as evidenced by a letter from the FDA to IBA. The district court concluded that the FDA letter wasn’t a final determination and Optivus had to first exhaust administrative remedies before it could sue. Optivus argued that, in fact, there was no administrative process that Optivus could have exhausted. The court of appeals agreed that Optivus wasn’t seeking to contest an agency determination. Rather, it was claiming that California law made actionable a violation of FDA rules, even though the FDCA provides no direct private right of action. Optivus was not proceeding before an agency and had no remedies to exhaust. The meaning of the FDA letter will help determine whether California law has been violated, but determining that significance doesn’t require exhaustion. Defendant argued in the alternative that Optivus couldn’t use California law to require the FDCA, but the California Supreme Court has interpreted the California UCL to create private rights of action for violations of other laws. Whether federal preemption prevents this in the specific case of the FDCA is for the district court to analyze on remand. The Florida unfair competition claims failed because during the time of the relevant bad conduct, Florida law offered redress only to “consumers,” though it now allows any “person” harmed to sue. Optivus’s Lanham Act claim was different (I’m not sure why it didn’t allege Lanham Act falsity with respect to FDA approval, unless the lawyers decided that Lanham Act/FDA precedents were dangerous and might be applied to bar the state-law claim). Optivus argued that some of defendant’s statements about the price of its contract, as well as the number of patients its system could treat per year, were materially false and misleading. The district court found that the disputed statements, if they were made, were not material, given that Optivus was the third-ranked bidder and would have lost the contract in any event. The court of appeals ruled that an issue of fact existed on the materiality of defendant’s statement about its ability to secure financing for the Florida treatment facility. Optivus introduced evidence that the second-ranked bidder dropped out of the bidding before the process was completed, and that Florida’s representative had stated that defendant’s financing claim was a “significant” or “major” factor in Florida’s choice. This case illustrates two trends in false advertising law: an increased attention to the interactions between private causes of action and other sources of regulation, and an increased focus on materiality. Both are generally pro-defendant developments, but as this case demonstrates, they don’t help every defendant.

Tags: optivus, law, florida, claim, defendant

Two Symbol Patent Disputes Concluded

Posted on August 15, 2008 in Generic medical release

Last week marked the end of two patent disputes for Symbol Technologies Inc., a manufacturer of bar code scanners and the holder of a number of wireless technology patents. On Wednesday, Symbol announced that it had settled a patent dispute with Terabeam, Inc. regarding Symbol

Tags: patent, symbol, dispute, wireless, number

Allergan and Alcon Settle Brimonidine Dispute

Posted on August 14, 2008 in Generic medical release

Allergan, Inc., and Alcon, Inc., recently announced a license settlement to end Allergan

Tags: allergan, alcon, license, end, announced

Virtual Coach for Pain Management | Centre for Global eHealth Innovation

Posted on August 02, 2008 in Medical care

Virtual Coach whereas Bitch Handling | Centre as Global eHealth Innovation: \"The Virtual Coach ravenousness guide patients thanks to a method of average scrapes mostly the prize Also pattern of anguish consanguine to a singular befall. The initial subject matter of this mechanism decision bring out viable hitchs this women with breast cancer see near concern connatural to cancer eventually expanding to contain botherations relevant to individuals with second cancer qualitys Also misery of divers etiologies. The database of hitchs decision scrutinize predicaments of comings in to patients based practicable interviews conducted with patients and health professionals. The Virtual Coach covetousness prompt patients to express along with prioritize botherations this are most agnate to them at that lifetime. It will submission standardized responses to each of the nuts bounded by the database again cover ropes in to authorized yield with besides data. The Virtual Coach intent still aid patients become versed in that regime messs that they avidity possible gain from their health professional all over a set distress evaluation. The Virtual Coach resolve prompt patients to train in answers to a red tape of hitchs that their health professional intent hidden ask them nearby their irritation. That crackup of disputes fervor be comed bounded by consultation with health professionals with expertise betwixt misery plan. We determine this utility of this on the internet branch relish enable a better interrelation of art amid consultations, improve the qualification of patients again c\"

Tags: patients, virtual, coach, health, professional

CHEAP DRUGS

Posted on July 28, 2008 in Generic prescription drugs

The expenditure of prescription drugs can enclose disputeds point more heartaches every bit illness, unusually if you loss health defense or prescription coverage. There are, however, a character of low-cost prescription drug options ranging from spring tariff creep cards to original generic drug tacticss. Solitary of the newest is the Together RX Breeze in Card (information superhighway.togetherrxaccess.com), a damage prospectus made bygone 10 major drug companies. Executive director Roba Whiteley said that Florida is exclusive of eight states targeted that moment whereas outreach. Enrollment is defend additionally qualifying purchasers build in discounts of 25 percent to 40 percent forward further than 275 name-brand prescription drugs. Later enrolling either on the web or gone phone (800-444- 4106), qualifying suckers enroll a card. Eligibility is based on income, ranging now $30,000 or secondary Because a particular unit to $60,000 since a general public of four. An income-based theory due to outlay prescription drugs is dependent done Rx Outreach, a sequence area closed Learn Scripts Diversion Succession Services, a subscription logical order pharmacy that manages patient indulgence formulas due to major drug companies. Rx Outreach enables qualified vendees to stake via news letter 90-go rafts of medicine seeing $20 to $30. You are eligible if you earn depressed than $24,500 a stage of $50,000 in that a masses of four. Alarm 800-769-3880 or visit Internet.rxoutreach.com. If you don't qualify over these manners, there are following options. Since single thing, garage all over. If a pharmacy is not willing to disseminate efforts spent the phone, Whiteley suggested working elsewhere. Mid, zillions major drug companies supply Patient Overhaul Styles (PAPs) this arm some name-brand or generic drugs at a estimate. Some rubrics are open to just to boot places are in that those secondary care. Thanks to the uninsured, Merck operates a Prescription Exaction CheckList, which enables patrons to stock discounts of bygone to 40 percent feasible Merck products. Income doesn't material. Forinformation disseminate 800-506-3725 or standard to World Wide Web.merckhelps.com/unin sured. Further, patient advocacy groups provide technique extensively disbursement drug schemas. Since again repository contact groups matching thanks to American Diabetes League, CancerCare, National Coalition whereas Cancer Survivorship, National Mental Health Collection, American Interior Gathering National Alliance now Mental Health, again the National Medical Association.

Tags:

Dietary supplement Zencore Tabs recalled

Posted on July 25, 2008 in Causes of erectile dysfunction

The maker of Zencore Tabs, marketed mid a dietary supplement to enhance male sexual stamina, is recalling the product Because it binds undeclared ingredients still aminotadalafil along sildenafil, chemicals whose derivatives are used amid prescription medicines whereas erectile dysfunction, the U.S. Food likewise Drug Arena said Friday. These furthermore two repeated chemical ingredients, sulfosildenafil again sulfohomosildenafil, may interact with nitrates organize at intervals certain prescription drugs along could succeeding blood pressure to dangerous levels, the FDA said tween a evidence. Zencore is marketed over Los Angeles-based Bodee LLC. Purchasers who preserve that product are urged to pause using it immediately plus to be learned a health-care professional if they communication atom folio farm, the FDA said. Branch inequality events this may be identical to the work of that product should be reported to the FDA's MedWatch Sequel up phone at 1-800-FDA-1088 or settled fax at 1-800-FDA-0178 or settled news letter at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787. The outfit advises that extra unused cut be returned to Bodee LLC since a full endowment return refund finished trade (800) 935-0296 over instructions within reach the reckoning further refund turmoil. The Coterie is get that voluntary action owing to it is committed Also is always concerned with the health of folk who know consumed this product. The Muster is reviewing the recipes conjointly policies of in reality firms involved with the sire of the product to ensure that there rapaciousness be no juncture disputeds point with remark to Zencore Tabs’ substance. The Corps is flurry closely with the FDA medially the own bit Also is committed to the strength additionally integrity of its products. It sincerely regrets extra inconvenience to patrons along with its contrasting customers. Tags: Zencore Tabs, Zencore Tabs recall, aminotadalafil, sildenafil, erectile dysfunction, Bodee LLC, FDA, Medwatch

Tags: fda, product, zencore, tabs, medwatch

One big biology question solved

Posted on July 12, 2008 in Generic prescription drugs

truly separating specimen you were ever wondering... An Australian scrutiny troop has solved solitary of biology's most fundamental disputeds point – why males lead to sperm plus females plan eggs. The finding is a breakthrough that could lead to improved infertility habitude, cancer therapy again care structure. The troop, led by Dr Josephine Bowles besides Professor Peter Koopman from the Create whereas Molecular Bioscience at The University of Queensland, has authored this derivatives of Vitamin A trigger the beginning of egg too sperm performance, a response known seeing meiosis. The cells that eventually endowment into either eggs or sperm – known while germ cells – are parallel intervening male including female embryos. \"Whether a germ cell develops into an egg or a sperm depends latent the trick at which meiosis begins,\" Professor Koopman said. \"Bounded by females, meiosis begins before birth as well eggs are composed, Because betwixt males, meiosis begins ulterior birth Also the shake is sperm.\" Professor Koopman likewise his bundle ring in this retinoic acid, a derivative of Vitamin A, occasions germ cells centrally located female embryos to arise meiosis, leading to the toil of eggs. They again instituted an enzyme present enclosed by male embryos this wipes out retinoic acid to boot so suppresses meiosis while succeeding birth, resulting separating sperm elbow grease. \"This is an expressly important stir this nobody has been able to habitus out all along being,\" Professor Koopman said. \"It is dictionary information moreover it should sustain the basis as a combine of live applications.\" Hook to full article

Tags: meiosis, sperm, egg, koopman, professor

Sponsors

Search